This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Giorgi M and Yun H (2012) Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: a pilot study. The Veterinary Journal192, 239–241
Quimby JM and Lunn KF (2013) Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial. The Veterinary Journal197, 651–655
Richter C and Martin KM (2024) The use of mirtazapine as an adjunct agent to fluoxetine and paroxetine in the treatment of canine fear-, anxiety-, and aggression-based disorders: A retrospective study of 71 cases. Journal of Veterinary Behavior71, 9–17
Spano V, Springer CM, Christensen, EL and Albright JD (2023) Effects of transdermal mirtazapine and oral gabapentin as pre-veterinary visit pharmaceuticals for shelter cats. Journal of Veterinary Behavior64, 47–53
Watson F, Rusbridge C, Packer RM et al. (2018) A review of treatment options for behavioural manifestations of clinical anxiety as a comorbidity in dogs with idiopathic epilepsy. The Veterinary Journal 238, 1–9
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
